Age/Gen | Method for diagnosis | Sample preparation method | IEP | Immunostaining | Detail of amyloid protein | Size of amyloid protein | Structural abnormality of amyloid protein | Reported year | Ref |
---|---|---|---|---|---|---|---|---|---|
65/F | WB/AASA | Amyloid purification | IgG-κ | ND | VH + Cγ3 | 22 kDa | VH directly contiguous with CH3 | 1990 | [9] |
59/M | WB/AASA | Amyloid purification | IgG-κ | K(−), λ(−) | vH | 11 kDa | VH with truncated D segment | 1994 | [10] |
64/M | Immunostaining | IgA-κ | IgA(+), κ(−), λ(−) | NA | NA | NA | 2002 | [11] | |
56/M | Immunostaining | IgM-λ | IgM(+), κ(−), λ(−) | NA | NA | NA | 2003 | [12] | |
53/F | Immunostaining | IgG-λ | IgG(+), κ(−), λ(+) | NA | NA | NA | 2003 | [13] | |
72/F | AASA | Amyloid purification | IgG-λ | IgG(−), κ(−), λ(−) | vH | 11 kDa | truncated VH | 2004 | [14] |
61/F | AASA | Amyloid purification | IgG-κ | IgG(−), κ(−), λ(−) | vH | 11 kDa | VH with truncated D segment | 2006 | [15] |
67/M | LC-MS/MS | Amyloid purification | IgM-κ | K(−), λ(−) | vH | 11 kDa | truncated VH | 2008 | [16] |
50/M | LC-MS/MS | LMD | IgG-λ | ND | VH + Cγ3 | NA | NA | 2010 | [2] |
36/M | LC-MS/MS | LMD | IgG-κ | IgG(+), IgA(+), IgM(+), κ(+), λ(+) | VH + Cγ3 | NA | NA | 2010 | [2] |
ND | LC-MS/MS | LMD | IgA-λ | IgA(+), λ(+) | VH + Cα1 | NA | NA | 2013 | [3] |
ND | LC-MS/MS | LMD | IgG-λ | IgG(+), λ(+) | Cγ1 | NA | NA | 2013 | [3] |
ND | LC-MS/MS | LMD | negative | IgG(+) | Cγ1, Cγ4 | NA | NA | 2013 | [3] |
ND | Immunostaining | IgG-λ | IgG1,(+) | NA | NA | NA | 2013 | [3] | |
70/F | LC-MS/MS | Amyloid purification | IgG-λ | IgG(−), κ(−), λ(−) | VH + Cγ1 | 11 kDa | VH with truncated CHI | 2015 | [17] |